poisar

Stocks · News reference

Ashland Launches permexa Sodium Caprate To Advance Oral Delivery Of Peptides, Biologics, And GLP‑1 Therapies

BenzingaAug 24, 2026, 11:02 AMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 24, 2026, 11:02 AM
Checked
Aug 24, 2026, 1:28 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARAug 10, 2026, 8:30 PMSEC EDGAR

    8-K/A filing — ASHLAND INC. (ASH)

    Filed: 2026-08-10 AccNo: 0001193125-26-342480 Size: 145 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

    Read original at edgar